ARCC-4 is primarily utilized in the field of oncology research, particularly in the development of targeted cancer therapies. It functions as a small molecule inhibitor, specifically designed to disrupt certain signaling pathways that are crucial for cancer cell survival and proliferation. Researchers employ ARCC-4 to study its efficacy in blocking these pathways, which can lead to the inhibition of tumor growth and metastasis. Its application extends to preclinical studies, where it is tested in various cancer models to evaluate its potential as a therapeutic agent. Additionally, ARCC-4 is used in combination studies with other anticancer drugs to assess synergistic effects, aiming to enhance treatment outcomes and reduce drug resistance. The compound is also valuable in molecular biology research, helping to elucidate the mechanisms of cancer progression and the role of specific molecular targets in disease pathology.